What Clinical Trials Show at Studied Doses Microdosing discussions often reference full-dose research because those trials are the only rigorous data available for understanding how these medications behave
Differences were observed in exposure of certain drugs when co-administered with oral semaglutide compared to administration alone, AUC of furosemide increased by 28%, and C max decreased by 34%, 63 AUC of rosuvastatin increased by 41%, and C max increased by 10%, 63 AUC of metformin increased by 32%, 57 a small increase in exposure of furosemide and rosuvastatin 59 and minor increases in AUC of Levothyroxine
This is a 70% increase over the previous dose, and it is the point where many researchers experience the most dramatic shift in appetite regulation and body composition changes
Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
Medications like semaglutide and tirzepatide are game-changers in the revolutionary treatment of obesity and type 2 diabetes
Bottom line Tirzepatide and semaglutide can both be effective treatments for weight loss